Data mining and knowledge discovery tools for human microbiome big data

The human microbiome is a fundamental component of human physiology, with an estimated one-third of circulating metabolites being a product of the gut microbiota. Changes in the microbiome can trigger changes in human cellular activities, resulting in disease or contribute to its progression. Microbiota is considered to be a virtual "code" or a system emerging, with the properties that must be integrated into the biology and physiology of the human. Unlike the other components, the functions of this "code" are not yet fully understood but can be quite easily disturbed by diet, diseases, and the various treatments. Recently, it becomes more and more clear that these functions can be beneficial both and with the negative impact on the health status of the human host. The recognition of the role of soil microflora in the intestinal diseases and neurological or in metabolic diseases of systemic triggered an avalanche of studies which also were aimed at the elucidation of the human microbiome (Human Microbiome Project), but also a complicated interaction between the bi-directional relationship between the human and the intestinal bacteria. An important step represents the discovery of potential methods of use of human microbiota in prevention and treatment of diseases such as autism, asthma, Parkinson disease, obesity, and diabetes. There is an impressive collection of data (Human Microbiome Big Date) which can be analyzed and classified using the algorithms of Data Mining or Knowledge Discovery Date Tools.

[1]  Qiang Feng,et al.  A metagenome-wide association study of gut microbiota in type 2 diabetes , 2012, Nature.

[2]  Adrian Streinu-Cercel,et al.  Gut microbiota and its complex role. The experience of the National Institute for Infectious Diseases “Prof. Dr. Matei Balş” in fecal bacteriotherapy for Clostridium difficile infection , 2013, BMC Infectious Diseases.

[3]  Oana Geman,et al.  Mini-review: Human Microbiome project — Recent trends and future challenges , 2015, 2015 E-Health and Bioengineering Conference (EHB).

[4]  R. Ismagilov,et al.  Gene-targeted microfluidic cultivation validated by isolation of a gut bacterium listed in Human Microbiome Project's Most Wanted taxa , 2014, Proceedings of the National Academy of Sciences.

[5]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[6]  T. de Wouters,et al.  Up-regulation of intestinal type 1 taste receptor 3 and sodium glucose luminal transporter-1 expression and increased sucrose intake in mice lacking gut microbiota , 2011, British Journal of Nutrition.

[7]  Oana Geman,et al.  Partitioning methods used in DBS treatments analysis results , 2011, The 2011 International Joint Conference on Neural Networks.

[8]  F. Duca,et al.  Current and emerging concepts on the role of peripheral signals in the control of food intake and development of obesity , 2012, British Journal of Nutrition.

[9]  Rob Knight,et al.  Analysis of composition of microbiomes: a novel method for studying microbial composition , 2015, Microbial ecology in health and disease.

[10]  C. Huttenhower,et al.  Inflammatory bowel disease as a model for translating the microbiome. , 2014, Immunity.

[11]  Yoshimasa Tanaka,et al.  Risk Factors Contributing to Type 2 Diabetes and Recent Advances in the Treatment and Prevention , 2014, International journal of medical sciences.

[12]  V. Tremaroli,et al.  Functional interactions between the gut microbiota and host metabolism , 2012, Nature.

[13]  Guigang Zhang,et al.  Deep Learning , 2016, Int. J. Semantic Comput..

[14]  Curtis Huttenhower,et al.  Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission , 2014, The ISME Journal.

[15]  M. Li,et al.  Structural Changes of Gut Microbiota during Berberine-Mediated Prevention of Obesity and Insulin Resistance in High-Fat Diet-Fed Rats , 2012, PloS one.

[16]  Denis Roy,et al.  Probiotics as Complementary Treatment for Metabolic Disorders , 2015, Diabetes & metabolism journal.

[17]  Qiang Feng,et al.  The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment , 2015, Nature Medicine.

[18]  Jürgen Schmidhuber,et al.  Deep learning in neural networks: An overview , 2014, Neural Networks.

[19]  Susan M. Huse,et al.  Oligotyping analysis of the human oral microbiome , 2014, Proceedings of the National Academy of Sciences.

[20]  S. Sørensen,et al.  Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults , 2010, PloS one.

[21]  Emily B. Hollister,et al.  From Prediction to Function Using Evolutionary Genomics: Human-Specific Ecotypes of Lactobacillus reuteri Have Diverse Probiotic Functions , 2014, Genome biology and evolution.

[22]  Wei Song,et al.  Targeting gut microbiota as a possible therapy for diabetes. , 2015, Nutrition research.

[23]  H. Flint,et al.  Role of the gut microbiota in nutrition and health , 2018, British Medical Journal.

[24]  G. Musso,et al.  Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders , 2010, Current opinion in lipidology.

[25]  R. Ismagilov,et al.  Individually addressable arrays of replica microbial cultures enabled by splitting SlipChips. , 2014, Integrative biology : quantitative biosciences from nano to macro.

[26]  Hui-Young Lee,et al.  Human originated bacteria, Lactobacillus rhamnosus PL60, produce conjugated linoleic acid and show anti-obesity effects in diet-induced obese mice. , 2006, Biochimica et biophysica acta.

[27]  Oana Geman Data Mining Tools Used in Deep Brain Stimulation - Analysis Results , 2011, EANN/AIAI.

[28]  E. Zoetendal,et al.  Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. , 2012, Gastroenterology.

[29]  Masashi Yanagisawa,et al.  Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41 , 2008, Proceedings of the National Academy of Sciences.

[30]  Patrice D Cani,et al.  Diabetes, obesity and gut microbiota. , 2013, Best practice & research. Clinical gastroenterology.

[31]  L. Proctor,et al.  The Human Microbiome Project in 2011 and beyond. , 2011, Cell host & microbe.

[32]  Francesco Salvatore,et al.  The role of the gut microbiome in the healthy adult status. , 2015, Clinica chimica acta; international journal of clinical chemistry.